ATE519109T1 - Präeklampsie-diagnose - Google Patents

Präeklampsie-diagnose

Info

Publication number
ATE519109T1
ATE519109T1 AT05857213T AT05857213T ATE519109T1 AT E519109 T1 ATE519109 T1 AT E519109T1 AT 05857213 T AT05857213 T AT 05857213T AT 05857213 T AT05857213 T AT 05857213T AT E519109 T1 ATE519109 T1 AT E519109T1
Authority
AT
Austria
Prior art keywords
pregnancy
preeclampsia
risk
levels
present
Prior art date
Application number
AT05857213T
Other languages
English (en)
Inventor
Irina Buhimschi
Catalin Buhimschi
Errol Norwitz
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of ATE519109T1 publication Critical patent/ATE519109T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05857213T 2004-12-21 2005-12-21 Präeklampsie-diagnose ATE519109T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63794804P 2004-12-21 2004-12-21
PCT/US2005/047010 WO2006069373A2 (en) 2004-12-21 2005-12-21 Diagnosis of preeclampsia

Publications (1)

Publication Number Publication Date
ATE519109T1 true ATE519109T1 (de) 2011-08-15

Family

ID=36602368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05857213T ATE519109T1 (de) 2004-12-21 2005-12-21 Präeklampsie-diagnose

Country Status (7)

Country Link
US (3) US7727733B2 (de)
EP (2) EP1839056B1 (de)
JP (1) JP5009811B2 (de)
CN (1) CN101163970A (de)
AT (1) ATE519109T1 (de)
ES (2) ES2475975T3 (de)
WO (1) WO2006069373A2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335362B2 (en) * 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
DK2308507T3 (da) * 2002-07-19 2015-04-20 Beth Israel Hospital Fremgangsmåder til behandling af præeklampsi
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
US8273383B2 (en) * 2004-05-04 2012-09-25 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
US7740849B2 (en) 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
DK1804836T3 (da) 2004-09-24 2011-01-24 Beth Israel Hospital Fremgangsmåder til diagnosticering og behandling af graviditetskomplikationer
JP2008523816A (ja) 2004-12-15 2008-07-10 ベス イスラエル ディーコネス メディカル センター 妊娠合併症の診断および処置に有用な核酸およびポリペプチド
ATE519109T1 (de) * 2004-12-21 2011-08-15 Univ Yale Präeklampsie-diagnose
US20060257901A1 (en) * 2005-03-24 2006-11-16 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
EP1946121A2 (de) 2005-10-27 2008-07-23 Yale University, Inc. Proteomische harn-biomarkermuster bei präeklampsie
US20070111326A1 (en) * 2005-11-14 2007-05-17 Abbott Laboratories Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
DE602006015964D1 (de) * 2006-09-20 2010-09-16 Roche Diagnostics Gmbh Natriurethische Peptide und Plazenta-Wachstumfaktor/löslicher VEGF-Rezeptor unterscheiden zwischen mit der Plazenta verbundener Herzdysfunktion und mit Herzerkrankung verbundener Herzdysfunktion
WO2008075363A1 (en) 2006-12-20 2008-06-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
CN101259119B (zh) * 2007-03-08 2010-05-19 上海市计划生育科学研究所 一种丝氨酸蛋白酶抑制剂及其衍生物在生育调节中的应用
US8835183B2 (en) 2008-01-07 2014-09-16 Ortho-Clinical Diagnostics, Inc. Determination of sFlt-1:angiogenic factor complex
US8148157B2 (en) 2008-01-07 2012-04-03 Ortho-Clinical Diagnostics, Inc. Reference, calibrator, or control composition of PIGF-1 and sFlt-1
WO2009094665A1 (en) * 2008-01-25 2009-07-30 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
WO2009108073A1 (en) * 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease
WO2010062377A2 (en) * 2008-10-31 2010-06-03 Yale University Methods and compositions for the detection and treatment of preeclampsia
MX2011005454A (es) * 2008-11-24 2011-06-20 Corthera Inc Prediccion y prevencion de preeclampsia.
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
CN101643785B (zh) * 2009-06-18 2011-12-21 中国人民解放军第二军医大学 用于妊娠高血压综合症检测的hsa-mir-210试剂盒及检测方法
WO2011128357A2 (en) * 2010-04-13 2011-10-20 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
US20110251094A1 (en) 2010-04-13 2011-10-13 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
US8969322B2 (en) 2010-05-14 2015-03-03 Beth Israel Deconess Medical Center, Inc. Extracorporeal devices and methods of treating complications of pregnancy
CA2886489A1 (en) 2011-10-14 2013-04-18 Aarhus Universitet Diagnostic and prognostic use of prombp-complexes
US20150087553A1 (en) * 2012-04-13 2015-03-26 Bioscreening and Diagnostics, LLC Early trimester screening for early- and late-onset preeclampsia
HK1206790A1 (en) * 2012-05-08 2016-01-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for providing a preeclampsia assessment
SG11201407667UA (en) 2012-06-27 2015-02-27 Hoffmann La Roche MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
SG11201501065QA (en) * 2012-09-04 2015-03-30 Pluristem Ltd Methods for prevention and treatment of preeclampsia
RU2519083C1 (ru) * 2012-10-29 2014-06-10 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ ОММ" Минздравсоцразвития России) Способ прогноза гипертензионных осложнений беременности у пациенток с гестационным сахарным диабетом
GB201303649D0 (en) 2013-03-01 2013-04-17 Univ Aston Hydrogen sulphide compounds
CN103207274B (zh) * 2013-04-28 2015-02-25 成都中医药大学 一种胎儿7号染色体异常疾病的筛查试剂盒
CN105917233B (zh) 2014-01-24 2018-07-03 豪夫迈·罗氏有限公司 产后hellp综合征、产后子痫或产后子痫前期的预测
FR3017955B1 (fr) * 2014-02-27 2018-04-06 Assistance Publique - Hopitaux De Paris Biomarqueurs diagnostics de la cardiomyopathie du peripartum
CA3157573C (en) 2014-04-10 2025-11-18 Yale University METHODS AND COMPOSITIONS FOR DETECTING MISFOLDED PROTEINS
EP3175239A1 (de) * 2014-07-30 2017-06-07 Matthew Cooper Verfahren und zusammensetzungen zur diagnose, prognose und bestätigung von präeklampsie
WO2016132136A1 (en) * 2015-02-18 2016-08-25 Aston University Diagnostic assay and treatment for preeclampsia
CN108700591A (zh) * 2015-09-11 2018-10-23 洛斯安第斯大学 用于鉴定妊娠相关疾病的体外方法
CL2018000664A1 (es) 2015-09-11 2019-02-08 Univ Los Andes Método in vitro para identificar una enfermedad relacionada con el embarazo
CN107884570A (zh) * 2016-09-29 2018-04-06 韦彦余 一种孕妇先兆子痫检测试剂盒
CN109891239B (zh) * 2016-10-24 2022-04-05 苏州爱尔迪思生物科技有限公司 用于提供子痫前期评估和预测早产的方法和试剂盒
EP3559253A4 (de) * 2016-12-20 2020-08-26 Sangui Bio Pty. Ltd Blutprofilerstellung mit proteaseinhibitoren
CN111094988A (zh) 2017-09-13 2020-05-01 普罗根尼蒂公司 先兆子痫生物标志物及相关系统和方法
CN109557320A (zh) * 2018-11-26 2019-04-02 余波澜 辅助检测胎盘植入的试剂盒及其应用
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
US12436155B2 (en) 2020-04-16 2025-10-07 Kalia Health, Inc. Preeclampsia screening device and methods measuring activin and/or inhibin A
US20230298758A1 (en) * 2020-11-06 2023-09-21 The Board Of Trustees Of The Leland Stanford Junior University Systems and Methods for Evaluating Gestational Progress and Applications Thereof
US20220298364A1 (en) 2021-03-18 2022-09-22 The Patent Well LLC Corrosion-Inhibiting Coatings for Metal Mesh Gaskets and Metallic Particles
AU2022405688A1 (en) 2021-12-08 2024-06-06 B.R.A.H.M.S Gmbh Biomarkers for prognosis of early onset preeclampsia
AU2023390798A1 (en) 2022-12-08 2025-06-12 B.R.A.H.M.S Gmbh Multiple sflt-1 measurements for prognosis of early onset preeclampsia
CN116953255A (zh) * 2023-07-27 2023-10-27 山东大学 血清中总IgM和/或总IgG在子痫前期预测或诊断中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5998216A (en) 1996-10-01 1999-12-07 Beth Israel Deaconess Medical Center Stabilizing formulation for preserving the integrity of proteins present in a body fluid sampled ex-vivo for evaluation as a specimen
WO1998028006A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
CA2430889A1 (en) * 2002-06-19 2003-12-19 Bayer Corporation Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
EP1515997A1 (de) 2002-06-21 2005-03-23 ExxonMobil Chemical Patents Inc. Ethylen- polymerisationskatalysator basiert auf yttrium mit amidinate als sperrige zusätzliche liganden
DK2308507T3 (da) * 2002-07-19 2015-04-20 Beth Israel Hospital Fremgangsmåder til behandling af præeklampsi
DK1388734T3 (da) * 2002-08-01 2004-05-03 Mtm Lab Ag Metode til opløsningsbaseret diagnose
AU2003288027A1 (en) * 2002-11-16 2004-06-15 Dade Behring Marburg Gmbh Scd40l, papp-a and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases
JP2008523816A (ja) 2004-12-15 2008-07-10 ベス イスラエル ディーコネス メディカル センター 妊娠合併症の診断および処置に有用な核酸およびポリペプチド
ATE519109T1 (de) * 2004-12-21 2011-08-15 Univ Yale Präeklampsie-diagnose
EP1946121A2 (de) 2005-10-27 2008-07-23 Yale University, Inc. Proteomische harn-biomarkermuster bei präeklampsie

Also Published As

Publication number Publication date
US7935496B2 (en) 2011-05-03
EP2434283A3 (de) 2012-07-11
CN101163970A (zh) 2008-04-16
JP2008524635A (ja) 2008-07-10
US8871448B2 (en) 2014-10-28
WO2006069373A2 (en) 2006-06-29
JP5009811B2 (ja) 2012-08-22
WO2006069373A8 (en) 2006-09-14
EP1839056B1 (de) 2011-08-03
EP1839056A4 (de) 2008-05-21
EP1839056A2 (de) 2007-10-03
EP2434283A2 (de) 2012-03-28
EP2434283B1 (de) 2014-03-26
US20100227342A1 (en) 2010-09-09
US20120040371A1 (en) 2012-02-16
WO2006069373A3 (en) 2006-11-23
US20060183175A1 (en) 2006-08-17
ES2475975T3 (es) 2014-07-11
US7727733B2 (en) 2010-06-01
ES2371084T3 (es) 2011-12-27

Similar Documents

Publication Publication Date Title
ATE519109T1 (de) Präeklampsie-diagnose
WO2004089187A3 (en) Caries risk test for predicting and assessing the risk of disease
Tripodi et al. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism
Jenner Serum free light chains in clinical laboratory diagnostics
CA3157573C (en) METHODS AND COMPOSITIONS FOR DETECTING MISFOLDED PROTEINS
ATE452343T1 (de) Verbesserte vitamin-d-messung
ATE395812T1 (de) Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
WO2009137015A3 (en) Biomarkers of ionizing radiation
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
Giavarina et al. Reference interval of D-dimer in pregnant women
ATE438860T1 (de) P1gf und flt-1 als prognostische parameter bei kardiovaskulären erkrankungen
CN102224422A (zh) 使用pigf-2和pigf-3标志物确定先兆子痫风险的方法
EP2287618A3 (de) Verfahren zur Diagnose neurodegenerativer Erkrankungen
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
WO2003023352A3 (en) Saliva-based methods for preventing and assessing the risk of diseases
MX2012002797A (es) Panel multimarcador para hipertrofia ventricular izquierda.
JP2018536170A5 (de)
Cavalier et al. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
Pipkin et al. Predicting high blood pressure in pregnancy: a multivariate approach
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
DE60126991D1 (de) Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE
Nerenz et al. Estimating the hCGβcf in urine during pregnancy
CA2523690A1 (en) Use of protein masp as a marker for colorectal cancer
Bonebrake et al. Is fluorescence polarization reliable and cost efficient in a fetal lung maturity cascade?

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties